Chapter 3 TF

The risk of invasive breast cancer decreases with age.

Atypical lobular hyperplasia is not considered as lobular neoplasia.

Breast cancers are usually symptomatic at diagnosis.

Ultrasound is used to visualize distant metastasis in breast cancer staging.

The 'T4' stage in breast cancer indicates a tumor of any size with extension to the chest wall only.

The 'M0' designation in breast cancer staging signifies the presence of distant metastasis.

In the study, the 10-year post-treatment PSA recurrence free survival for T1, T2 tumors was higher for radiation compared to surgery.

According to the data provided, distant-free survival post-surgery decreases over time.

Lesions that show malignant changes but have not invaded are classified as in situ lesions.

AIs like anastrozole and exemestane are used in the treatment of invasive breast cancer.

Having a prior history of breast cancer increases the risk of developing DCIS.

Benign Breast Disease is not considered a risk factor for breast cancer according to the provided information.

Colon cancer can present as exophytic lesions?

Symptoms in tumors are indicative of early stage cancer?

In nodal metastases assessment, nodal micrometastases are always counted?

Radiation treatment alone is curative for individuals with metastatic colon cancer?

Chemotherapy and radiation treatment can eradicate micrometastasis?

High preoperative carcinoembryonic antigen (CEA) levels are not a prognostic factor for colon cancer?

Tumor size is not considered important when assessing risk in individuals with nodal spread.

Individuals with positive estrogen and progesterone receptors have higher early recurrence rates.

The oncogene associated with increased tumor aggressiveness is located on chromosome 16.

Overexpression of the oncogene predicts a decreased response to humanized antibody treatment.

Individuals with more aggressive tumor behavior tend to have better long-term outcomes.

Prophylactic bilateral mastectomy is a common approach for treating DCIS tumors.

The SEER Data mentioned in the text covers the period from 1973 to 2008.

The data presented on Page 115 is related to Colon Cancer Mortality by Stage and Grade.

The mortality rates for T1 are higher than T4 in the data provided.

According to the SEER Data, the mortality rate for Years 15-20 is lower than that for Years 0-5.

The SEER Data includes information on Colon Cancer Mortality based on the number of nodes affected.

Stages I and II have the same mortality rates according to the SEER Data.